| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/05/2011 | US20110104755 Antibodies immunoreactive with mutant hydroxypenylpyruvatedioxygenase |
| 05/05/2011 | US20110104723 Biomarkers |
| 05/05/2011 | US20110104706 Novel kinases and uses thereof |
| 05/05/2011 | US20110104705 Musclin receptor and use thereof |
| 05/05/2011 | US20110104701 Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer |
| 05/05/2011 | US20110104687 Methods and Kits for Detecting Congenital Stationary Night Blindness and Selecting Different Coat Patterns |
| 05/05/2011 | US20110104680 Recurrent gene fusions in lung cancer |
| 05/05/2011 | US20110104675 Methods and Compositions for Diagnosing Carcinomas |
| 05/05/2011 | US20110104666 Insulin resistance marker |
| 05/05/2011 | US20110104226 Peptides having binding affinity to an antibody which recognizes an epitope on an a1 loop 2 or beta2 loop 1 of an adrenoreceptor |
| 05/05/2011 | US20110104184 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 05/05/2011 | US20110104182 Cd40 antibody formulation and methods |
| 05/05/2011 | US20110104180 New vaccine for the treatment of mycobacterium related disorders |
| 05/05/2011 | US20110104178 Novel avian astrovirus |
| 05/05/2011 | US20110104176 Antibody specifically binding to c-met and use thereof |
| 05/05/2011 | US20110104174 Antibodies to receptor for advanced glycation end products (rage) and uses thereof |
| 05/05/2011 | US20110104171 EphA4 Polypeptide Having a Novel Activity and Use Thereof |
| 05/05/2011 | US20110104170 Novel composition and methods for the treatment of immune related diseases |
| 05/05/2011 | US20110104164 Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 05/05/2011 | US20110104163 Anti-hiv domain antibodies and method of making and using same |
| 05/05/2011 | US20110104160 Medicament for treating cancer |
| 05/05/2011 | US20110104156 Methods and materials for treating autoimmune and/or complement mediated diseases and conditions |
| 05/05/2011 | US20110104149 SingleC-9 Binding Agents |
| 05/05/2011 | US20110104148 Antibodies to Carcinoembryonic Antigen (CEA), Methods of Making Same, and Uses Thereof |
| 05/05/2011 | US20110104147 Identification of Tumor-Associated Markers for Diagnosis and Therapy |
| 05/05/2011 | US20110104143 Treating Basal-Like Genotype Cancers |
| 05/05/2011 | US20110104108 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
| 05/05/2011 | US20110104103 Method of conjugating therapeutic compounds to cell targeting devices via metal complexes |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | US20110104053 HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM |
| 05/05/2011 | CA2779257A1 Il-17a antagonists |
| 05/05/2011 | CA2778895A1 Compositions and methods for treating inflammatory disorders |
| 05/05/2011 | CA2778673A1 Function modifying nav 1.7 antibodies |
| 05/05/2011 | CA2778671A1 Antibodies to ion channels |
| 05/05/2011 | CA2778568A1 Antibody having activity of inhibiting hepatitis c virus (hcv) infection and use thereof |
| 05/05/2011 | CA2777698A1 Ax1 and ax189 pcsk9 antagonists and variants |
| 05/05/2011 | CA2777542A1 Ax213 and ax132 pcsk9 antagonists and variants |
| 05/05/2011 | CA2777312A1 Stable anti-tnfr1 polypeptides, antibody variable domains & antagonists |
| 05/05/2011 | CA2777068A1 Antibodies to epha3 |
| 05/05/2011 | CA2776990A1 Sorf constructs and multiple gene expression |
| 05/05/2011 | CA2775369A1 Clonal expansion of b cells |
| 05/05/2011 | CA2774919A1 Dosage regimen for administering a cd19xcd3 bispecific antibody |
| 05/05/2011 | CA2774441A1 Antibodies immunoreactive with mutant hydroxypenylpyruvate dioxygenase |
| 05/05/2011 | CA2773522A1 Method for the production of a glycosylated immunoglobulin |
| 05/04/2011 | EP2317317A1 Prion protein ligands and methods of use |
| 05/04/2011 | EP2316976A1 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 05/04/2011 | EP2316969A1 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| 05/04/2011 | EP2316951A1 Binding domain-immunoglobulin fusion proteins |
| 05/04/2011 | EP2316940A1 Focused libraries of genetic packages |
| 05/04/2011 | EP2316939A2 Novel peptide |
| 05/04/2011 | EP2316925A1 Circovirus sequences associated with porcine wasting disease (PWD) |
| 05/04/2011 | EP2316922A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316921A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316920A1 Clonal expansion of B cells |
| 05/04/2011 | EP2316859A1 Cathepsin S antibody |
| 05/04/2011 | EP2316858A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (NAIT) |
| 05/04/2011 | EP2316857A1 Monoclonal antibodies that specifically bind to folate receptor alpha |
| 05/04/2011 | EP2316856A1 Human monoclonal antibodies against CD20 |
| 05/04/2011 | EP2316855A1 Antihuman Alpha-9 integrin antibody and use of the same |
| 05/04/2011 | EP2316854A1 Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin D metabolite. |
| 05/04/2011 | EP2316853A2 Detection and modulation of slit and roundabout (robo) mediated angiogenesis and uses thereof |
| 05/04/2011 | EP2316852A1 Stabilized single domain antibodies |
| 05/04/2011 | EP2316851A1 Antibody inhibitors of GDF-8 and uses thereof |
| 05/04/2011 | EP2316845A1 Specific binding agents of human angiopoietin-2 |
| 05/04/2011 | EP2316843A1 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/04/2011 | EP2316493A2 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/04/2011 | EP2316487A1 Recombinant IL-9 antibodies & uses thereof |
| 05/04/2011 | EP2316486A2 Cripto blocking antibodies and uses thereof |
| 05/04/2011 | EP2316485A1 Use of bispecific antibodies to regulate immune responses |
| 05/04/2011 | EP2316484A1 Antibody specifically binding to C-MET and use thereof |
| 05/04/2011 | EP2316276A2 Genes encoding proteolytic enzymes from aspargilli |
| 05/04/2011 | EP2316033A2 Detection of prostate cancer using psa glycosylation patterns |
| 05/04/2011 | EP2315781A2 Fgf-r4 receptor-specific antagonists |
| 05/04/2011 | EP2315780A1 Compositions and methods of use for therapeutic antibodies |
| 05/04/2011 | EP2315779A2 Compositions comprising antibodies to lingo or fragments thereof |
| 05/04/2011 | EP2315778A2 Compositions monovalent for cd28 binding and methods of use |
| 05/04/2011 | EP2315777A1 Therapeutic use of specific ligand in msrv associated diseases |
| 05/04/2011 | EP2315600A2 Compositions and methods related to sirt1 function |
| 05/04/2011 | EP1831257B9 Humanized antibody specific for tumor necrosis factor-alpha |
| 05/04/2011 | EP1581560B1 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 05/04/2011 | EP1383532B1 Combination therapy |
| 05/04/2011 | EP1294746B1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 05/04/2011 | EP0815233B1 Novel avian cytokines and genetic sequences encoding same |
| 05/04/2011 | CN1926153B Pharmaceutical use of anti-TLR4 antibody |
| 05/04/2011 | CN1829529B Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof |
| 05/04/2011 | CN1703243B Pharmaceutical compositions directed to erb-b1 receptors |
| 05/04/2011 | CN102047113A Composition, kit and method for detecting neuropathy |
| 05/04/2011 | CN102047112A Composition, kit and method for detecting aging and disease associated with vascular disorder |
| 05/04/2011 | CN102046803A Monoclonal antibodies to basic fibroblast growth factor |
| 05/04/2011 | CN102046660A Immunoglobulin and/or toll-like receptor proteins associated with myelogenous haematological proliferative disorders and uses thereof |
| 05/04/2011 | CN102046659A Anti-FLT3 antibodies |
| 05/04/2011 | CN102046658A Binding members for interleukin-4 receptor alpha (IL-4Ralpha) - 173 |
| 05/04/2011 | CN102046657A Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof |
| 05/04/2011 | CN102046656A Neutralizing molecules to viral antigens |
| 05/04/2011 | CN102046655A BCR-complex-specific antibodies and methods of using same |
| 05/04/2011 | CN102046654A Antibodies against H5N1 strains of influenza a virus |
| 05/04/2011 | CN102046651A Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof |
| 05/04/2011 | CN102046650A Infection inhibitor |
| 05/04/2011 | CN102046207A Drug fusions and conjugates |
| 05/04/2011 | CN102043056A Preparation method for immune colloidal gold test strip for simultaneously detecting orchid viruses CyMV and ORSV |